Haemodialysis
Transforming Haemodialysis
Helping to Simplify and Improve the Quality of Haemodialysis Treatments
Baxter is committed to advancing haemodialysis in ground-breaking and meaningful ways. We do this by providing innovative products and services that help healthcare professionals improve the quality of treatments and simplify therapy delivery for the diverse and growing population of end-stage renal disease patients.
Haemodialysis Facts & Figures
~24,155
Adults were on in-centre haemodialysis at the end of 2020, which represented 35.4% of the KRT population1
100,000
Baxter HD monitors today help deliver effective haemodialysis2
1,377
Adults were on home haemodialysis at the end of 2020, which represented 2.0% of the KRT population1